ImmunityBio, Inc. - COM (IBRX)

Historical Portfolio Holders from Q1 2021 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
65.3 M
Holdings value Q1 2024
$351 M
Value change Q1 2024
+$50.1 M
Grand Portfolio weight change Q1 2024
+0%
Number of holders
151
Number of buys Q1 2024
79
Number of sells Q1 2024
-53
Average buys Q1 2024 %
+0%
Average sells Q1 2024 %
0%
CUSIP
45256X103
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 65.3 M $351 M +$50.1 M $5.37 151
2023 Q4 56.7 M $285 M +$53.6 M $5.02 139
2023 Q3 49.8 M $84 M +$17.8 M $1.69 130
2023 Q2 38.1 M $106 M -$9.11 M $2.78 109
2023 Q1 45.7 M $83.1 M -$34.9 M $1.82 140
2022 Q4 49.5 M $251 M +$53.7 M $5.07 128
2022 Q3 32.2 M $160 M +$30.1 M $4.97 109
2022 Q2 31.9 M $119 M -$11.1 M $3.72 118
2022 Q1 28.8 M $162 M +$2.5 M $5.61 130
2021 Q4 28.2 M $172 M +$15.7 M $6.08 122
2021 Q3 31.9 M $311 M +$41.7 M $9.74 119
2021 Q2 27.2 M $388 M +$155 M $14.28 119
2021 Q1 15.9 M $377 M +$377 M $23.74 112